Related Experiment Video
Updated: Jun 4, 2025

09:03
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
8.6K
School vaccination programmes to increase HPV vaccination coverage - Experiences from Bremen, Germany
Regina Singer1, Imke Hübotter2, Franziska Hölzner2
1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany; Postgraduate Training for Applied Epidemiology, Robert Koch Institute, Berlin, Germany; ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Vaccine
|December 19, 2024
Summary
Germany
Area of Science:
- Public Health
- Immunization Programs
- Epidemiology
Background:
- Germany's opportunistic immunization system has resulted in low Human Papillomavirus (HPV) vaccine coverage since its 2007 introduction.
- School-based vaccination is an international strategy to improve HPV vaccine uptake.
Purpose of the Study:
- To evaluate the effectiveness of a school-based HPV vaccination program in Bremen, Germany.
- To assess HPV vaccine uptake among vulnerable student populations based on socio-economic position.
Main Methods:
- Retrospective cohort study analyzing vaccination status of 8th-graders from 2015/16 to 2018/19 (girls) and 2022/23 (girls and boys).
- Sub-analyses utilized the School Social Index (SSI) to assess socio-economic disparities.
- Included 13,550 students across 56 schools.
Main Results:
- Annual uptake of school-based HPV vaccination among unvaccinated students was 26-35% for girls and 39% for boys.
- Vaccine uptake was significantly higher in lower socio-economic position schools (SSI 5: 37%) compared to higher SEP schools (SSI 1: 30%).
- One-third of unvaccinated students received at least one HPV vaccine dose at school, while two-thirds did not utilize the offer.
Conclusions:
- School-based HPV vaccination programs can increase vaccine uptake, particularly in lower socio-economic groups.
- Significant barriers to HPV vaccination persist, as two-thirds of students did not accept the school-based offer.
- Nationwide implementation in Germany faces challenges and may not overcome all uptake barriers, necessitating further investigation into vaccine hesitancy and preferences.
Related Concept Videos
Vaccinations
44.1K
Overview
44.1K
Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338

